{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:05:11Z","timestamp":1791230711430,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"UAE University","award":["31M127"],"award-info":[{"award-number":["31M127"]}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["630434"],"award-info":[{"award-number":["630434"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012769","name":"Neuroscience Research Australia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012769","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Alzheimer Brian Bank UK"},{"name":"Stichting Parkinson Fonds (SPF; The Netherlands)"},{"name":"Neuroscience Campus Amsterdam"},{"DOI":"10.13039\/501100002283","name":"Alzheimer\u2019s Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000320","name":"Alzheimer\u2019s Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000320","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Netherlands Brain Bank (Amsterdam, the Netherlands)"},{"name":"neuropathologist, VUmc"},{"name":"(Jutendo University Graduate School of Medicine, Japan"},{"name":"National Hospital Organization, Sagamihara National Hospital, Japan"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.nbd.2015.04.009","type":"journal-article","created":{"date-parts":[[2015,5,2]],"date-time":"2015-05-02T22:37:23Z","timestamp":1430606243000},"page":"81-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":144,"special_numbering":"C","title":["Generation and characterization of novel conformation-specific monoclonal antibodies for \u03b1-synuclein pathology"],"prefix":"10.1016","volume":"79","author":[{"given":"Nishant N.","family":"Vaikath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nour K.","family":"Majbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina E.","family":"Paleologou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa T.","family":"Ardah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"van Dam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma D.J.","family":"van de Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley L.","family":"Forrest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Parkkinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ping","family":"Gai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Takanashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Jae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.A.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzuru","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenda M.","family":"Halliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yi.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar M.A.","family":"El-Agnaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2015.04.009_bb0005","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fnagi.2014.00248","article-title":"Elevated levels of cerebrospinal fluid alpha-synuclein oligomers in healthy asymptomatic LRRK2 mutation carriers","volume":"6","author":"Aasly","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.nbd.2015.04.009_bb0010","doi-asserted-by":"crossref","first-page":"29739","DOI":"10.1074\/jbc.M600933200","article-title":"Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease","volume":"281","author":"Anderson","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2015.04.009_bb0015","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/mds.25421","article-title":"Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease","volume":"28","author":"Appel-Cresswell","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2015.04.009_bb0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3389\/fnagi.2014.00197","article-title":"Structure activity relationship of phenolic acid inhibitors of alpha-synuclein fibril formation and toxicity","volume":"6","author":"Ardah","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.nbd.2015.04.009_bb0025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.nbd.2014.11.007","article-title":"Ginsenoside Rb1 inhibits fibrillation and toxicity of alpha-synuclein and disaggregates preformed fibrils","volume":"74","author":"Ardah","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.04.009_bb0030","first-page":"879","article-title":"Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies","volume":"152","author":"Baba","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2015.04.009_bb0035","doi-asserted-by":"crossref","first-page":"13454","DOI":"10.1523\/JNEUROSCI.1292-12.2012","article-title":"Antibody-Aided Clearance of Extracellular \u03b1-Synuclein Prevents Cell-to-Cell Aggregate Transmission","volume":"32","author":"Bae","year":"2012","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.nbd.2015.04.009_bb0040","doi-asserted-by":"crossref","first-page":"E4274","DOI":"10.1073\/pnas.1416598111","article-title":"alpha-Synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation","volume":"111","author":"Burre","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2015.04.009_bb0045","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"Alpha-synuclein locus duplication as a cause of familial Parkinson's disease","volume":"364","author":"Chartier-Harlin","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2015.04.009_bb0050","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1073\/pnas.1218424110","article-title":"Large alpha-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking","volume":"110","author":"Choi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2015.04.009_bb0055","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.cell.2012.03.037","article-title":"Direct observation of the interconversion of normal and toxic forms of \u03b1-synuclein","volume":"149","author":"Cremades","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2015.04.009_bb0060","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2990.2006.00722.x","article-title":"Comparative study of commercially available anti-alpha-synuclein antibodies","volume":"32","author":"Croisier","year":"2006","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.nbd.2015.04.009_bb0065","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0002-9440(10)65220-0","article-title":"Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid","volume":"155","author":"Culvenor","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nbd.2015.04.009_bb0070","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0002-9440(10)65226-1","article-title":"Widespread alterations of alpha-synuclein in multiple system atrophy","volume":"155","author":"Dickson","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nbd.2015.04.009_bb0075","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ana.10279","article-title":"Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases","volume":"52","author":"Duda","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2015.04.009_bb0080","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1046\/j.1471-4159.1997.68010437.x","article-title":"Conformations of beta-amyloid in solution","volume":"68","author":"El-Agnaf","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2015.04.009_bb0105","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0014-5793(98)01418-5","article-title":"Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments","volume":"440","author":"El-Agnaf","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.nbd.2015.04.009_bb0090","article-title":"Improved solid-phase syntheses of amyloid proteins associated with neurodegenerative diseases","author":"El-Agnaf","year":"2000"},{"key":"10.1016\/j.nbd.2015.04.009_bb0095","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1021\/bi002287i","article-title":"Effect of the disulfide bridge and the C-terminal extension on the oligomerization of the amyloid peptide ABri implicated in familial British dementia","volume":"40","author":"El-Agnaf","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.nbd.2015.04.009_bb0085","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1474-4422(03)00481-2","article-title":"Soluble oligomers for the diagnosis of neurodegenerative diseases","volume":"2","author":"El-Agnaf","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2015.04.009_bb0100","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1096\/fj.03-1449com","article-title":"Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease","volume":"20","author":"El-Agnaf","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2015.04.009_bb0110","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/jnc.12175","article-title":"Monoclonal antibodies selective for alpha-synuclein oligomers\/protofibrils recognize brain pathology in Lewy body disorders and alpha-synuclein transgenic mice with the disease-causing A30P mutation","volume":"126","author":"Fagerqvist","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2015.04.009_bb0115","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"alpha-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.nbd.2015.04.009_bb0120","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1046\/j.1471-4159.1999.02093.x","article-title":"Alpha-synuclein immunoisolation of glial inclusions from multiple system atrophy brain tissue reveals multiprotein components","volume":"73","author":"Gai","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2015.04.009_bb0125","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/exnr.2000.7527","article-title":"In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies","volume":"166","author":"Gai","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2015.04.009_bb0130","doi-asserted-by":"crossref","first-page":"9441","DOI":"10.1523\/JNEUROSCI.5314-13.2014","article-title":"Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like models","volume":"34","author":"Games","year":"2014","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.nbd.2015.04.009_bb0135","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0","article-title":"A panel of epitope-specific antibodies detects protein domains distributed throughout human alpha-synuclein in Lewy bodies of Parkinson's disease","volume":"59","author":"Giasson","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2015.04.009_bb0140","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.290.5493.985","article-title":"Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions","volume":"290","author":"Giasson","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.nbd.2015.04.009_bb0145","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/alzrt255","article-title":"Levels of cerebrospinal fluid alpha-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease","volume":"6","author":"Hansson","year":"2014","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.nbd.2015.04.009_bb0150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0014-5793(94)00395-5","article-title":"Identification of two distinct synucleins from human brain","volume":"345","author":"Jakes","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.nbd.2015.04.009_bb0155","doi-asserted-by":"crossref","first-page":"6365","DOI":"10.1523\/JNEUROSCI.20-17-06365.2000","article-title":"Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain","volume":"20","author":"Kahle","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.04.009_bb0160","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.nbd.2015.04.009_bb0165","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00401-012-0964-x","article-title":"An antibody with high reactivity for disease-associated \u03b1-synuclein reveals extensive brain pathology","volume":"124","author":"Kovacs","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2015.04.009_bb0170","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease","volume":"18","author":"Kr\u00fcger","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2015.04.009_bb0175","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1021\/bi5002536","article-title":"Nonaggregated alpha-synuclein influences SNARE-dependent vesicle docking via membrane binding","volume":"53","author":"Lai","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.nbd.2015.04.009_bb0180","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ana.23894","article-title":"G51D \u03b1-synuclein mutation causes a novel parkinsonian-pyramidal syndrome","volume":"73","author":"Lesage","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2015.04.009_bb0185","doi-asserted-by":"crossref","first-page":"12924","DOI":"10.1074\/jbc.M306390200","article-title":"Proteasomal inhibition by alpha-synuclein filaments and oligomers","volume":"279","author":"Lindersson","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2015.04.009_bb0190","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1084\/jem.20112457","article-title":"Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice","volume":"209","author":"Luk","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.nbd.2015.04.009_bb0195","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.nbd.2015.04.009_bb0200","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2174\/0929866043407138","article-title":"Alpha-synuclein and the pathogenesis of Parkinson's disease","volume":"11","author":"Martin","year":"2004","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.nbd.2015.04.009_bb0205","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","article-title":"Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders","volume":"287","author":"Masliah","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.nbd.2015.04.009_bb0210","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.neuron.2005.05.010","article-title":"Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease","volume":"46","author":"Masliah","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2015.04.009_bb0215","doi-asserted-by":"crossref","first-page":"e19338","DOI":"10.1371\/journal.pone.0019338","article-title":"Passive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body disease","volume":"6","author":"Masliah","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nbd.2015.04.009_bb0220","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jneumeth.2010.08.010","article-title":"Production of a monoclonal antibody, against human alpha-synuclein, in a subpopulation of C57BL\/6J mice, presenting a deletion of the alpha-synuclein locus","volume":"192","author":"Mougenot","year":"2010","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.nbd.2015.04.009_bb0225","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3233\/JAD-2012-121393","article-title":"The ELISA-measured increase in cerebrospinal fluid tau that discriminates Alzheimer's disease from other neurodegenerative disorders is not attributable to differential recognition of tau assembly forms","volume":"33","author":"O'Dowd","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2015.04.009_bb0230","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1073\/pnas.022662599","article-title":"Conformational Abs recognizing a generic amyloid fibril epitope","volume":"99","author":"O'Nuallain","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2015.04.009_bb0235","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1042\/BST0331106","article-title":"Alpha-synuclein aggregation in neurodegenerative diseases and its inhibition as a potential therapeutic strategy","volume":"33","author":"Paleologou","year":"2005","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.nbd.2015.04.009_bb0240","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/brain\/awn349","article-title":"Detection of elevated levels of soluble alpha-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies","volume":"132","author":"Paleologou","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2015.04.009_bb0245","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2013.10","article-title":"Cerebrospinal fluid biomarkers in Parkinson disease","volume":"9","author":"Parnetti","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2015.04.009_bb0250","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fnagi.2014.00053","article-title":"Differential role of CSF alpha-synuclein species, tau, and Abeta42 in Parkinson's Disease","volume":"6","author":"Parnetti","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.nbd.2015.04.009_bb0255","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0304-3940(03)00781-X","article-title":"Epitope mapping and specificity of the anti-alpha-synuclein monoclonal antibody Syn-1 in mouse brain and cultured cell lines","volume":"349","author":"Perrin","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2015.04.009_bb0260","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.nbd.2015.04.009_bb0265","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1093\/brain\/awu057","article-title":"Accumulation of oligomer-prone alpha-synuclein exacerbates synaptic and neuronal degeneration in vivo","volume":"137","author":"Rockenstein","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2015.04.009_bb0270","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ana.21380","article-title":"Genomic investigation of alpha-synuclein multiplication and parkinsonism","volume":"63","author":"Ross","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2015.04.009_bb0275","doi-asserted-by":"crossref","first-page":"10732","DOI":"10.1073\/pnas.1321785111","article-title":"Intramuscular injection of alpha-synuclein induces CNS alpha-synuclein pathology and a rapid-onset motor phenotype in transgenic mice","volume":"111","author":"Sacino","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2015.04.009_bb0280","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0896-6273(03)00024-2","article-title":"The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease","volume":"37","author":"Sharon","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2015.04.009_bb0290","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2015.04.009_bb0285","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2015.04.009_bb0295","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0304-3940(98)00504-7","article-title":"Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies","volume":"251","author":"Spillantini","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2015.04.009_bb0300","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1212\/WNL.0b013e3181fd613b","article-title":"Detection of elevated levels of \u03b1-synuclein oligomers in CSF from patients with Parkinson disease","volume":"75","author":"Tokuda","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2015.04.009_bb0305","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.celrep.2014.05.033","article-title":"\u03b1-Synuclein Immunotherapy Blocks Uptake and Templated Propagation of Misfolded \u03b1-Synuclein and Neurodegeneration","volume":"7","author":"Tran","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2015.04.009_bb0310","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","article-title":"Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death","volume":"72","author":"Volpicelli-Daley","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2015.04.009_bb0315","doi-asserted-by":"crossref","first-page":"22364","DOI":"10.1074\/jbc.272.35.22364","article-title":"Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate","volume":"272","author":"Walsh","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2015.04.009_bb0320","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/j.cub.2014.08.027","article-title":"alpha-synuclein multimers cluster synaptic vesicles and attenuate recycling","volume":"24","author":"Wang","year":"2014","journal-title":"Curr. Biol."},{"key":"10.1016\/j.nbd.2015.04.009_bb0325","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00401-008-0375-1","article-title":"Characterization of antibodies that selectively detect alpha-synuclein in pathological inclusions","volume":"116","author":"Waxman","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2015.04.009_bb0330","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","article-title":"In vivo demonstration that alpha-synuclein oligomers are toxic","volume":"108","author":"Winner","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2015.04.009_bb0335","doi-asserted-by":"crossref","first-page":"19509","DOI":"10.1074\/jbc.274.28.19509","article-title":"alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease","volume":"274","author":"Wood","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2015.04.009_bb0340","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.neuroscience.2006.12.028","article-title":"Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody","volume":"145","author":"Yu","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2015.04.009_bb0345","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2015.04.009_bb0350","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1016\/j.bpj.2013.04.050","article-title":"In vitro study of alpha-synuclein protofibrils by cryo-EM suggests a Cu(2+)-dependent aggregation pathway","volume":"104","author":"Zhang","year":"2013","journal-title":"Biophys. J."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996115001564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996115001564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T19:46:54Z","timestamp":1748375214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996115001564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":70,"alternative-id":["S0969996115001564"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2015.04.009","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation and characterization of novel conformation-specific monoclonal antibodies for \u03b1-synuclein pathology","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2015.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}